CM
Conor McNamara RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
9.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.3%
Neutral
21.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Health Information Services
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $73 |
26%
upside
| 3 | +8.3% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $5 |
31%
upside
| 1 | +85% |
0
%
| 12 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $255 |
26%
upside
| 2 | +21% |
0
%
| 8 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $3 |
66%
upside
| 2 | -13% |
0
%
| 7 Aug ‘25 6 months ago |
|
|
|
Sector Perform
Maintained
| $46 |
56%
downside
| 1 | – |
–
| 7 Aug ‘25 6 months ago |
|
|
|
Outperform
Upgraded
| $87 |
15%
upside
| 3 | +12% |
0
%
| 6 Aug ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $17 |
97%
upside
| 2 | -18% |
0
%
| 4 Aug ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $126 |
2%
downside
| 3 | +17% |
0
%
| 1 Aug ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $409 |
44%
upside
| 2 | +9.1% |
0
%
| 1 Aug ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $204 |
62%
upside
| 2 | -4.9% |
0
%
| 30 Jul ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $637 |
24%
upside
| 1 | +19% |
0
%
| 24 Apr ‘25 10 months ago |
|
|
|
Outperform
Reiterated
| $250 |
22%
upside
| 1 | +6.6% |
0
%
| 23 Apr ‘25 10 months ago |
|